title: Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels.
abstract: Sera obtained in the immediate postmortem from 100 individuals, 64 neuropathologically diagnosed Alzheimer's disease (AD) cases and 36 nondemented controls, were analyzed for cholesterol, lipoproteins, apolipoproteins (Apo), and triglycerides. All individuals were ApoE genotyped, and the amounts of Abeta (N-40 and N-42) in cerebral cortex of AD and control subjects were determined. When compared to controls, AD individuals had significantly higher LDL cholesterol (P = 0.006), ApoB (P = 0.018), Abeta N-40 (P = 0.024) and Abeta N-42 (P < 0.001), and significantly lower HDL cholesterol (P = 0.040). There were positive correlations between the levels of serum total cholesterol (r = 0.359, P = 0.004), LDL cholesterol (r = 0.328, P = 0.008), and ApoB (r = 0.395, P = 0.001) to the amount of Abeta N-42 in AD brains, but not to Abeta N-40. These correlations were independent of ApoE genotype and were not seen in the control group. The present results suggest for the first time that elevated serum cholesterol, especially in the form of LDL, influences the expression of AD-related pathology.
authors.affiliation: Haldeman Laboratory for Alzheimer Disease Research, Sun Health Research Institute, 10515 West Santa Fe Drive, Sun City, Arizona, 85351, USA.
authors.forename: Y M
authors.initials: YM
authors.lastname: Kuo
authors.forename: M R
authors.initials: MR
authors.lastname: Emmerling
authors.forename: C L
authors.initials: CL
authors.lastname: Bisgaier
authors.forename: A D
authors.initials: AD
authors.lastname: Essenburg
authors.forename: H C
authors.initials: HC
authors.lastname: Lampert
authors.forename: D
authors.initials: D
authors.lastname: Drumm
authors.forename: A E
authors.initials: AE
authors.lastname: Roher
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology*; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D001053:Apolipoproteins / Q000097:blood; D001057:Apolipoproteins E / Q000235:genetics; D001921:Brain / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000235:genetics / Q000378:metabolism; D005838:Genotype; D006801:Humans; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008077:Lipoproteins, LDL / Q000378:metabolism*; D010446:Peptide Fragments / Q000378:metabolism*; D012307:Risk Factors
chemical_list: D016229:Amyloid beta-Peptides; D001053:Apolipoproteins; D001057:Apolipoproteins E; D008055:Lipids; D008074:Lipoproteins; D008077:Lipoproteins, LDL; D010446:Peptide Fragments; C075222:amyloid beta-protein (1-42)